In patient 1, EBV capsid-IgG antibodies were positive and EBV–IgM antibodies negative, indicating a history of primary EBV infection; EBNA-IgG-antibodies remained negative up to the age of nine years (time of last follow-up control without SCIG substitution therapy). The gene discussed is CD40LG; the disease is Epstein-Barr virus infection.